A Clinical Trial to Assess Subjects With Dry Eye Disease.
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
A Multi-Center Randomized, Double-Masked, Parallel Design, Vehicle-Controlled Phase 2
Clinical Trial to Assess the Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution
Compared to Vehicle in Subjects with Dry Eye Disease